BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30528986)

  • 1. Peripheral Blood or Bone Marrow Stem Cells? Practical Considerations in Hematopoietic Stem Cell Transplantation.
    Amouzegar A; Dey BR; Spitzer TR
    Transfus Med Rev; 2019 Jan; 33(1):43-50. PubMed ID: 30528986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3
    Lum SH; James B; Ottaviano G; Ewins AM; Patrick K; Ali S; Carpenter B; Silva J; Tewari S; Furness C; Thomas A; Shenton G; Bonney D; Moppett J; Hambleton S; Gennery AR; Amrolia P; Gibson B; Hough R; Rao K; Slatter M; Wynn R
    Transplant Cell Ther; 2024 Mar; 30(3):314.e1-314.e12. PubMed ID: 38103787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
    Jo T; Arai Y; Kondo T; Mizuno S; Hirabayashi S; Inamoto Y; Doki N; Fukuda T; Ozawa Y; Katayama Y; Kanda Y; Fukushima K; Matsuoka KI; Takada S; Sawa M; Ashida T; Onizuka M; Ichinohe T; Atsuta Y; Kanda J; Yanada M
    Cytotherapy; 2022 Oct; 24(10):1013-1025. PubMed ID: 35729020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
    Remberger M; Ringdén O; Blau IW; Ottinger H; Kremens B; Kiehl MG; Aschan J; Beelen DW; Basara N; Kumlien G; Fauser AA; Runde V
    Blood; 2001 Sep; 98(6):1739-45. PubMed ID: 11535506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study.
    Fauser AA; Basara N; Blau IW; Kiehl MG
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S27-31. PubMed ID: 10933183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
    Bensinger WI; Clift R; Martin P; Appelbaum FR; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner CD
    Blood; 1996 Oct; 88(7):2794-800. PubMed ID: 8839878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.
    Campregher PV; Hamerschlak N; Colturato VA; Mauad MA; de Souza MP; Bouzas LF; Tavares Rde C; Barros JC; Chiattone R; Paz A; Silla L; Vigorito AC; Miranda E; Funke VA; Flowers ME
    Eur J Haematol; 2015 Nov; 95(5):421-5. PubMed ID: 25645430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis.
    Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Eur J Haematol; 2014 Jul; 93(1):19-28. PubMed ID: 24527665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.
    Pidala J; Anasetti C; Kharfan-Dabaja MA; Cutler C; Sheldon A; Djulbegovic B
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1415-21. PubMed ID: 19822301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
    McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
    Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A
    Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.